Light-Targeted Therapies Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Light-Targeted Therapies Market: By Type (Photodynamic Therapy, Photoimmunotherapy, Photothermal Therapy),  By Indication (Head and Neck Cancer, Actinic Keratosis, Macular Degeneration, Polypoidal Choroidal Vasculopathy, Cervical Intraepithelial Neoplasia, Bladder Cancer, Barrett’s Esophagus, Gastric Cancer, Lung Cancer, Port-Wine Stain, Others), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

1. Executive Summary
2. Global Light-Targeted Therapies Market Introduction
2.1. Global Light Targeted Therapies Market – Taxonomy
2.2. Global Light Targeted Therapies Market –Definitions
2.2.1. By Type
2.2.2. By Indication
2.2.3. By Region
3. Global Light Targeted Therapies Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. R&D Trends
3.5. Pipeline Drugs
3.6. List of Developers
3.7. Clinical Developmental Status (End Points, Dose Regimen, and Others)
3.8. Disease Landscape
3.9. Global Light Targeted Therapies Market Dynamic Factors – Impact Analysis
3.10. Three Forecast Scenarios – Pessimistic, Conservative and Opportunistic
3.11. Mapping Market Players Activities
3.12. Recent Key Developments
3.13. Financial Status of the Market Players
3.14. Recent Acquisitions, Collaborations and Mergers
4. Global Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Light Targeted Therapies Market Forecast, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Photodynamic Therapy
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Photoimmunotherapy
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Photothermal Therapy
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Light Targeted Therapies Market Forecast, By Indication, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Head and Neck Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Actinic Keratosis
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Macular Degeneration
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Polypoidal Choroidal Vasculopathy
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Cervical Intraepithelial Neoplasia
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Bladder Cancer
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Barrett’s Esophagus
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Gastric Cancer
6.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.9. Lung Cancer
6.9.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.9.3. Market Opportunity Analysis
6.10. Port-Wine Stain
6.10.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.10.3. Market Opportunity Analysis
6.11. Others
6.11.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.11.3. Market Opportunity Analysis
7. Global Light Targeted Therapies Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Light Targeted Therapies Market – Opportunity Analysis Index, By Type, by Indication, and Region, 2022 – 2028
8. North America Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.1.1. Photodynamic Therapy
8.1.2. Photoimmunotherapy
8.1.3. Photothermal Therapy
8.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Head and Neck Cancer
8.2.2. Actinic Keratosis
8.2.3. Macular Degeneration
8.2.4. Polypoidal Choroidal Vasculopathy
8.2.5. Cervical Intraepithelial Neoplasia
8.2.6. Bladder Cancer
8.2.7. Barrett’s Esophagus
8.2.8. Gastric Cancer
8.2.9. Lung Cancer
8.2.10. Port-Wine Stain
8.2.11. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
8.5. North America Light Targeted Therapies Market Dynamics – Trends
9. Europe Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.1.1. Photodynamic Therapy
9.1.2. Photoimmunotherapy
9.1.3. Photothermal Therapy
9.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Head and Neck Cancer
9.2.2. Actinic Keratosis
9.2.3. Macular Degeneration
9.2.4. Polypoidal Choroidal Vasculopathy
9.2.5. Cervical Intraepithelial Neoplasia
9.2.6. Bladder Cancer
9.2.7. Barrett’s Esophagus
9.2.8. Gastric Cancer
9.2.9. Lung Cancer
9.2.10. Port-Wine Stain
9.2.11. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
9.5. Europe Light Targeted Therapies Market Dynamics – Trends
10. Asia-Pacific Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.1.1. Photodynamic Therapy
10.1.2. Photoimmunotherapy
10.1.3. Photothermal Therapy
10.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Head and Neck Cancer
10.2.2. Actinic Keratosis
10.2.3. Macular Degeneration
10.2.4. Polypoidal Choroidal Vasculopathy
10.2.5. Cervical Intraepithelial Neoplasia
10.2.6. Bladder Cancer
10.2.7. Barrett’s Esophagus
10.2.8. Gastric Cancer
10.2.9. Lung Cancer
10.2.10. Port-Wine Stain
10.2.11. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
10.5. Asia-Pacific Light Targeted Therapies Market Dynamics – Trends
11. Latin America Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Photodynamic Therapy
11.1.2. Photoimmunotherapy
11.1.3. Photothermal Therapy
11.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Head and Neck Cancer
11.2.2. Actinic Keratosis
11.2.3. Macular Degeneration
11.2.4. Polypoidal Choroidal Vasculopathy
11.2.5. Cervical Intraepithelial Neoplasia
11.2.6. Bladder Cancer
11.2.7. Barrett’s Esophagus
11.2.8. Gastric Cancer
11.2.9. Lung Cancer
11.2.10. Port-Wine Stain
11.2.11. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
11.5. Latin America Light Targeted Therapies Market Dynamics – Trends
12. Middle East and Africa Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Photodynamic Therapy
12.1.2. Photoimmunotherapy
12.1.3. Photothermal Therapy
12.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Head and Neck Cancer
12.2.2. Actinic Keratosis
12.2.3. Macular Degeneration
12.2.4. Polypoidal Choroidal Vasculopathy
12.2.5. Cervical Intraepithelial Neoplasia
12.2.6. Bladder Cancer
12.2.7. Barrett’s Esophagus
12.2.8. Gastric Cancer
12.2.9. Lung Cancer
12.2.10. Port-Wine Stain
12.2.11. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
12.5. MEA Light Targeted Therapies Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Rakuten Medical
13.2.2. Novartis
13.2.3. Galderma
13.2.4. ADVANZ PHARMA
13.2.5. Biofrontera
13.2.6. Sun Pharma
13.2.7. Modulight Corporation
13.2.8. biolitec Pharma
13.2.9. Luzitin
13.2.10. Nanospectra Biosciences
13.2.11. Photoatomic
13.2.12. Steba biotech
13.2.13. Theralase
14. Research Methodology
15. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

 

  • Rakuten Medical
  •  Novartis
  •  Galderma
  •  ADVANZ PHARMA
  •  Biofrontera
  •  Sun Pharma
  •  Modulight Corporation
  •  biolitec Pharma
  •  Luzitin
  •  Nanospectra Biosciences
  •  Photoatomic
  •  Steba biotech
  •  Theralase

Description

1. Executive Summary
2. Global Light-Targeted Therapies Market Introduction
2.1. Global Light Targeted Therapies Market – Taxonomy
2.2. Global Light Targeted Therapies Market –Definitions
2.2.1. By Type
2.2.2. By Indication
2.2.3. By Region
3. Global Light Targeted Therapies Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. R&D Trends
3.5. Pipeline Drugs
3.6. List of Developers
3.7. Clinical Developmental Status (End Points, Dose Regimen, and Others)
3.8. Disease Landscape
3.9. Global Light Targeted Therapies Market Dynamic Factors – Impact Analysis
3.10. Three Forecast Scenarios – Pessimistic, Conservative and Opportunistic
3.11. Mapping Market Players Activities
3.12. Recent Key Developments
3.13. Financial Status of the Market Players
3.14. Recent Acquisitions, Collaborations and Mergers
4. Global Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Light Targeted Therapies Market Forecast, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Photodynamic Therapy
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Photoimmunotherapy
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Photothermal Therapy
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Light Targeted Therapies Market Forecast, By Indication, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Head and Neck Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Actinic Keratosis
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Macular Degeneration
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Polypoidal Choroidal Vasculopathy
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Cervical Intraepithelial Neoplasia
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Bladder Cancer
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Barrett’s Esophagus
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Gastric Cancer
6.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.9. Lung Cancer
6.9.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.9.3. Market Opportunity Analysis
6.10. Port-Wine Stain
6.10.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.10.3. Market Opportunity Analysis
6.11. Others
6.11.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.11.3. Market Opportunity Analysis
7. Global Light Targeted Therapies Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Light Targeted Therapies Market – Opportunity Analysis Index, By Type, by Indication, and Region, 2022 – 2028
8. North America Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.1.1. Photodynamic Therapy
8.1.2. Photoimmunotherapy
8.1.3. Photothermal Therapy
8.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Head and Neck Cancer
8.2.2. Actinic Keratosis
8.2.3. Macular Degeneration
8.2.4. Polypoidal Choroidal Vasculopathy
8.2.5. Cervical Intraepithelial Neoplasia
8.2.6. Bladder Cancer
8.2.7. Barrett’s Esophagus
8.2.8. Gastric Cancer
8.2.9. Lung Cancer
8.2.10. Port-Wine Stain
8.2.11. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
8.5. North America Light Targeted Therapies Market Dynamics – Trends
9. Europe Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.1.1. Photodynamic Therapy
9.1.2. Photoimmunotherapy
9.1.3. Photothermal Therapy
9.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Head and Neck Cancer
9.2.2. Actinic Keratosis
9.2.3. Macular Degeneration
9.2.4. Polypoidal Choroidal Vasculopathy
9.2.5. Cervical Intraepithelial Neoplasia
9.2.6. Bladder Cancer
9.2.7. Barrett’s Esophagus
9.2.8. Gastric Cancer
9.2.9. Lung Cancer
9.2.10. Port-Wine Stain
9.2.11. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
9.5. Europe Light Targeted Therapies Market Dynamics – Trends
10. Asia-Pacific Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.1.1. Photodynamic Therapy
10.1.2. Photoimmunotherapy
10.1.3. Photothermal Therapy
10.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Head and Neck Cancer
10.2.2. Actinic Keratosis
10.2.3. Macular Degeneration
10.2.4. Polypoidal Choroidal Vasculopathy
10.2.5. Cervical Intraepithelial Neoplasia
10.2.6. Bladder Cancer
10.2.7. Barrett’s Esophagus
10.2.8. Gastric Cancer
10.2.9. Lung Cancer
10.2.10. Port-Wine Stain
10.2.11. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
10.5. Asia-Pacific Light Targeted Therapies Market Dynamics – Trends
11. Latin America Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Photodynamic Therapy
11.1.2. Photoimmunotherapy
11.1.3. Photothermal Therapy
11.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Head and Neck Cancer
11.2.2. Actinic Keratosis
11.2.3. Macular Degeneration
11.2.4. Polypoidal Choroidal Vasculopathy
11.2.5. Cervical Intraepithelial Neoplasia
11.2.6. Bladder Cancer
11.2.7. Barrett’s Esophagus
11.2.8. Gastric Cancer
11.2.9. Lung Cancer
11.2.10. Port-Wine Stain
11.2.11. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
11.5. Latin America Light Targeted Therapies Market Dynamics – Trends
12. Middle East and Africa Light Targeted Therapies Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Photodynamic Therapy
12.1.2. Photoimmunotherapy
12.1.3. Photothermal Therapy
12.2. Pressure Range Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Head and Neck Cancer
12.2.2. Actinic Keratosis
12.2.3. Macular Degeneration
12.2.4. Polypoidal Choroidal Vasculopathy
12.2.5. Cervical Intraepithelial Neoplasia
12.2.6. Bladder Cancer
12.2.7. Barrett’s Esophagus
12.2.8. Gastric Cancer
12.2.9. Lung Cancer
12.2.10. Port-Wine Stain
12.2.11. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Light Targeted Therapies Market – Opportunity Analysis Index, By Type, Indication, and Country, 2022 – 2028
12.5. MEA Light Targeted Therapies Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Rakuten Medical
13.2.2. Novartis
13.2.3. Galderma
13.2.4. ADVANZ PHARMA
13.2.5. Biofrontera
13.2.6. Sun Pharma
13.2.7. Modulight Corporation
13.2.8. biolitec Pharma
13.2.9. Luzitin
13.2.10. Nanospectra Biosciences
13.2.11. Photoatomic
13.2.12. Steba biotech
13.2.13. Theralase
14. Research Methodology
15. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX